Letter of concern to gov’t sparks quick ER responsesIn the wake of Dr. Paul Parks’ now famous e-mail outlining concern over ER overcrowding, the province has made some progress on the issue. Colchicine safe for patients with comorbidities Rheumatoid arthritis biologics may provoke shingles outbreaks Researchers advise clinicians to be vigilant when prescribing anti-TNF therapy Impotency drug cures Raynaud’s fingertip ulcers Arthritis biologics may cut Alzheimer’s risk Early treatment improves outcomes in rheumatoid arthritis Methotrexate-prednisone combo achieves remission in nearly two-thirds of patients Lowering urate cuts cardiovascular deaths Hyperuricemia deserves more aggressive treatment, researcher says RxA and province resume talks On Dec. 1, talks around the Alberta Pharmaceutical Strategy resumed as Alberta’s Pharmacy Transition Team met to discuss the Alberta Pharmaceutical Strategy. Oral acyclovir improves CNS outcomes in neonatal herpes simplex Rate and degree of neutropenia found less than expected, but monitoring is needed CPhA survey confirms drug shortages causing havoc Some pharmacists spending three hours per shift addressing shortages, research finds. First Previous 1091 1092 1093 1094 1095 Next Last
